These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM. Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
6. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E. Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
12. India: New patent law may restrict access to HIV/AIDS treatments. Cruess G. HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971 [Abstract] [Full Text] [Related]
14. Old drugs, new uses: solving a Hatch-Waxman patent predicament. McPhie DC. Food Drug Law J; 2004 Aug; 59(1):155-68. PubMed ID: 15190929 [No Abstract] [Full Text] [Related]
15. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime. Halliburton M. Glob Public Health; 2009 Aug; 4(6):515-27. PubMed ID: 19548158 [Abstract] [Full Text] [Related]
16. Canada to change patent law to allow export of cheap drugs. Kondro W. Lancet; 2003 Oct 18; 362(9392):1290. PubMed ID: 14577437 [No Abstract] [Full Text] [Related]